Breast Cancer Patient Equity Act

Hozzl · 2024-12-20T09:06:21Z

Explore the details of House Bill 4779 Breast Cancer Patient Equity Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

12/20/2024, 9:06 AM

Summary of Bill HR 4779

The Breast Cancer Patient Equity Act, also known as Bill 118 hr 4779, is a piece of legislation currently being considered by the US Congress. The purpose of this bill is to ensure that breast cancer patients have access to necessary treatments and services without facing financial barriers.

One key provision of the bill is to require insurance companies to cover breast cancer treatments, including surgeries, chemotherapy, and radiation therapy, at the same level as other medical conditions. This would prevent patients from being denied coverage or facing high out-of-pocket costs for their care.

Additionally, the Breast Cancer Patient Equity Act aims to improve access to clinical trials for breast cancer patients. By requiring insurance companies to cover the costs associated with participating in clinical trials, more patients would have the opportunity to access cutting-edge treatments and potentially life-saving therapies. Overall, the goal of Bill 118 hr 4779 is to ensure that breast cancer patients receive equitable and affordable care, regardless of their insurance coverage. This legislation is important in addressing the financial burdens that many patients face when seeking treatment for this serious and often life-threatening disease.

Congressional Summary of HR 4779

Breast Cancer Patient Equity Act

This bill provides for Medicare coverage of custom fabricated breast prostheses following the surgical removal of the breast (i.e., a mastectomy), including replacements of such prostheses. Currently, Medicare covers surgically implanted breast prostheses, as well as some external breast prostheses (e.g., post-surgical bras).

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 4779

Bill HR 4779 is currently in the status of Bill Introduced since July 20, 2023. Bill HR 4779 was introduced during Congress 118 and was introduced to the House on July 20, 2023. Bill HR 4779's most recent activity was Referred to the Subcommittee on Health. as of December 17, 2024

Bipartisan Support of Bill HR 4779

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 4779

Primary Policy Focus

Health

Potential Impact Areas

CancerHealth care coverage and accessHealth technology, devices, suppliesMedicareSurgery and anesthesiaWomen's health

Alternate Title(s) of Bill HR 4779

Breast Cancer Patient Equity ActBreast Cancer Patient Equity ActTo amend title XVIII of the Social Security Act to provide coverage for custom fabricated breast prostheses following a mastectomy.

Start holding our government accountable!